Glucose Variability vs HbA1c for Non-Diabetics: Why Your Average Misses the Story

Your Blood Sugar Isn't What You Think It Is

Imagine two people with identical HbA1c levels of 5.4%. Person A maintains steady glucose between 85-110 mg/dL throughout the day. Person B swings from 65 to 180 mg/dL after every meal, but averages out to the same number. Their lab reports look identical. Their metabolic realities couldn't be more different.

This is the fundamental problem with HbA1c for anyone without diabetes who wants to understand their metabolic health. It's like judging a roller coaster and a flat highway by their average elevation. Technically accurate. Completely useless for understanding the actual experience.

The PREDICT study, published in Nature Medicine in 2024, tracked continuous glucose responses in over 1,000 participants and found something that changes how we should think about blood sugar entirely. Glycemic variability—not average glucose—predicted metabolic outcomes and cardiovascular risk markers in people with completely normal HbA1c levels.

What HbA1c Actually Measures (And What It Misses)

HbA1c reflects the percentage of hemoglobin proteins in your red blood cells that have glucose attached to them. Since red blood cells live about 90-120 days, this gives you a weighted average of your blood sugar over roughly three months. Higher sustained glucose means more glycated hemoglobin.

For managing diabetes, this metric revolutionized care. It gave doctors and patients a reliable number that couldn't be gamed by eating well the week before a fasting glucose test.

But here's what HbA1c fundamentally cannot tell you:

• How high your glucose spikes after meals
• How low it drops between meals or during sleep
• How quickly your body returns to baseline after eating
• Whether your glucose pattern looks like gentle rolling hills or jagged mountain peaks

A 2024 review in Diabetes Care examined these limitations extensively. The authors noted that among individuals with HbA1c below 5.7%—the conventional "normal" range—glucose variability patterns varied by as much as 400%. Same average, wildly different metabolic signatures.

Glucose Variability Metrics That Actually Matter

The ATTD 2025 consensus statement on CGM metrics for non-diabetic populations identified several measures that capture what HbA1c misses.

Coefficient of Variation (CV%) calculates how much your glucose fluctuates relative to your mean. A CV below 20% indicates stable glucose patterns. Above 36% signals significant variability that may warrant attention. Most metabolically healthy individuals fall between 17-25%.

Time in Range (TIR) measures what percentage of the day your glucose stays within target bounds. For non-diabetics, the emerging target is 70-140 mg/dL, with optimal health associated with spending 85% or more of time in this window.

Mean Amplitude of Glycemic Excursions (MAGE) captures the average size of your significant glucose swings throughout the day. Lower is generally better—think gentle waves rather than tsunami-sized spikes.

The PREDICT study found that participants in the highest quartile of glucose variability had 2.3 times higher levels of inflammatory markers compared to those in the lowest quartile, despite similar HbA1c values. Inflammation, not average glucose, appears to be the mechanism linking variability to downstream health effects.

The PREDICT Study Changed Everything

Tim Spector's ZOE PREDICT research did something unprecedented. Rather than studying people with diabetes, the team recruited healthy adults and tracked their glucose responses to standardized meals using continuous monitors.

The findings upended conventional thinking. Identical twins eating identical meals showed different glucose responses. The same person eating the same meal on different days showed different responses. Individual variation dominated.

But the most striking finding related to variability patterns. Participants with higher glucose variability—regardless of their average levels—showed:

• Elevated postprandial triglycerides (28% higher on average)
• Increased visceral fat accumulation over the 12-month follow-up
• Higher fasting insulin levels, suggesting developing insulin resistance
• Greater inflammatory marker elevation (hs-CRP, IL-6)

The correlation between glucose variability and these metabolic markers was stronger than the correlation with HbA1c. For non-diabetics, how your glucose moves matters more than where it averages.

Why Spikes Matter More Than Averages

The biological explanation involves oxidative stress. When glucose rises rapidly, it triggers a cascade of reactive oxygen species production in your mitochondria. Your cells can handle gradual changes efficiently. Rapid spikes overwhelm the system.

Research published in Diabetes Care 2024 demonstrated that acute glucose excursions above 160 mg/dL—even in people with normal HbA1c—activated endothelial dysfunction markers within 30 minutes. The endothelium is the lining of your blood vessels. Repeated dysfunction episodes contribute to atherosclerosis development over years and decades.

Think of it like exercise. Gradual increases in heart rate during a jog are healthy stress. Sudden spikes from zero to maximum repeatedly throughout the day would damage your cardiovascular system. Glucose works similarly.

One PREDICT participant, a 34-year-old woman with an HbA1c of 5.2%, showed glucose spikes to 185 mg/dL after eating white rice—well into the range typically seen in prediabetes. Her average looked perfect. Her post-meal reality suggested metabolic vulnerability that standard testing would never detect.

Practical Implications for Non-Diabetics

If you're considering wearing a CGM for health optimization rather than diabetes management, focus on these metrics rather than chasing a lower average glucose:

Track your CV% over 14-day periods. Aim for below 25%. If you're consistently above 30%, examine which meals, sleep patterns, or stress factors correlate with your highest variability days.

Monitor your time above 140 mg/dL. The ATTD consensus suggests non-diabetics should spend less than 5% of time above this threshold. That's roughly 70 minutes per day maximum. If you're exceeding this after specific meals, you've identified an intervention point.

Pay attention to overnight patterns. Glucose should be remarkably stable during sleep—typically between 70-100 mg/dL with minimal variation. Overnight variability often signals issues with evening meal timing, alcohol consumption, or sleep quality that affect metabolic health.

The Diabetes Care review noted that lifestyle interventions targeting variability reduction—meal timing, fiber intake, post-meal walks—often improved metabolic markers even when average glucose and HbA1c remained unchanged. You can improve your metabolic health without moving the number your doctor checks.

The Limitations of Variability Metrics

This isn't a case for abandoning HbA1c entirely. The metric remains valuable for screening, for tracking diabetes management, and for population-level health assessment. Insurance covers it. Doctors understand it. It's standardized across labs worldwide.

Glucose variability metrics from CGMs have their own issues. Sensor accuracy varies—most consumer CGMs have a mean absolute relative difference (MARD) of 9-11%, meaning readings can be off by that percentage. A reading of 140 mg/dL might actually be 126 or 154.

Day-to-day variation is normal and expected. Stressing over every spike defeats the purpose. The ATTD consensus specifically warned against over-interpretation of single-day data in non-diabetic users.

And we don't yet have long-term outcome studies proving that reducing glucose variability in healthy people prevents disease. The associations are strong. The biological mechanisms are plausible. The randomized controlled trials proving causation don't exist yet.

A More Complete Picture

The future of metabolic health assessment probably isn't HbA1c versus glucose variability. It's both, interpreted together.

HbA1c tells you your average exposure. Variability metrics tell you the pattern of that exposure. Combined with fasting insulin, lipid panels, and inflammatory markers, you get a multidimensional view of metabolic health that no single number can provide.

For non-diabetics interested in optimization rather than disease management, the PREDICT findings suggest that variability deserves at least as much attention as average glucose. Your HbA1c of 5.3% might look identical to your neighbor's. Your metabolic futures might look very different depending on what's happening between those averaged data points.

The roller coaster and the highway both have the same average elevation. Only one of them is trying to make you sick.